Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks sink on fears over Scottish referendum, Ukraine

Mon, 08th Sep 2014 11:36

Concerns surrounding the upcoming referendum on Scottish independence and a fragile ceasefire agreement in Ukraine were weighing heavily on UK stocks on Monday.London's FTSE 100 was trading down 1% at 6,789 by midday. The index has not closed below the 6,800 mark since 22 August when it settled at 6,775.25.The pound was trading at a 10-month low as the ‘yes’ campaign for Scottish independence gathered steam, with supporters for the break-up taking a narrow lead in a Yougov pool just 10 days before the vote. This was the first lead for the 'yes' lead since the campaign began.Businesses with large Scottish exposure were also rocked by the increased support for independence, with their shares suffering steep falls in morning trading."One could also question how much store we can put in a single poll. For now, the markets are certainly beginning to price in what was deemed unthinkable," said market strategist Brenda Kelly from IG Group.In other news, Ukraine and Russia accused each other of violating the ceasefire that was agreed on Friday, as shelling and gunfire in east Ukraine resumed on Sunday.The city of Mariupol, where a woman was killed on Sunday night, remains in Ukrainian hands but reports say the town on the Sea of Azov could soon come under assault from pro-Russian rebels. Blasts were also heard in Donetsk with both parties reciprocally accusing each other of firing first and threatening the truce.AB Foods and financials in the redFood, ingredients and retail group Associated British Foods fell despite reiterating its guidance for profit growth in the year to 13 September. AB Foods said that strong profit performances from the Primark and grocery divisions and an improvement in ingredients are expected to offset the adverse effect of lower sugar prices and the £50m impact from the recent strength in sterling.Banking and financial stocks were under pressure as investors speculated about how an independent Scotland could affect business. Lloyds, RBS and Standard Life were unwanted, along with utility firm SSE.RBS was also falling heavily after Credit Suisse listed it as one of its "key underperforms" in the European banking sector. HSBC and Standard Chartered were also rated 'underperform'.Glaxosmithkline was trading lower after Credit Suisse slashed its earnings forecasts for the company and trimmed its target price from 1,475p to 1,400p. The bank kept an 'underperform' rating for the stock, saying that it trades at a 10% premium to others in the sector.De La Rue gained after being named preferred bidder for a 10-year contract to print bank notes for the Bank of England from April 2015.Veterinary drugs firm Dechra Pharmaceuticals was also higher after a turnaround in the second half helped full-year revenues to rise 1.6%. The company also said underlying profits jumped 18% as it hiked its dividend by 10%.Market MoverstechMARK 2,828.65 -0.96%FTSE 100 6,788.67 -0.97%FTSE 250 15,702.50 -1.39%FTSE 100 - RisersRandgold Resources Ltd. (RRS) 4,772.00p +0.74%Mondi (MNDI) 1,052.00p +0.67%ARM Holdings (ARM) 960.00p +0.37%Tesco (TSCO) 229.25p +0.33%easyJet (EZJ) 1,370.00p +0.29%Burberry Group (BRBY) 1,496.00p +0.27%Shire Plc (SHP) 5,035.00p +0.20%Glencore (GLEN) 367.25p +0.07%FTSE 100 - FallersAssociated British Foods (ABF) 2,761.00p -5.09%Babcock International Group (BAB) 1,052.00p -4.97%Lloyds Banking Group (LLOY) 71.59p -3.26%Royal Bank of Scotland Group (RBS) 336.00p -3.17%Standard Life (SL.) 403.70p -3.07%Persimmon (PSN) 1,297.00p -2.85%SSE (SSE) 1,472.00p -2.58%Weir Group (WEIR) 2,649.00p -2.57%BAE Systems (BA.) 444.20p -2.54%Ashtead Group (AHT) 1,000.00p -2.34%FTSE 250 - RisersDe La Rue (DLAR) 770.00p +3.63%Supergroup (SGP) 1,223.00p +1.92%Dechra Pharmaceuticals (DPH) 745.00p +1.92%Fidelity China Special Situations (FCSS) 120.50p +1.69%Centamin (DI) (CEY) 66.80p +1.52%Templeton Emerging Markets Inv Trust (TEM) 624.00p +1.22%JPMorgan Emerging Markets Inv Trust (JMG) 605.00p +1.17%Genesis Emerging Markets Fund Ltd Ptg NPV (GSS) 577.00p +1.05%Polar Capital Technology Trust (PCT) 499.50p +1.01%JPMorgan American Inv Trust (JAM) 262.50p +0.88%FTSE 250 - FallersOcado Group (OCDO) 300.50p -5.56%Galliford Try (GFRD) 1,218.00p -4.47%Hochschild Mining (HOC) 162.00p -4.20%Brewin Dolphin Holdings (BRW) 276.30p -4.20%Diploma (DPLM) 654.00p -4.18%Debenhams (DEB) 64.45p -4.09%Ophir Energy (OPHR) 225.30p -3.84%Bellway (BWY) 1,530.00p -3.83%Exova Group (EXO) 180.70p -3.68%Morgan Advanced Materials (MGAM) 305.90p -3.62%
More News
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.